Join our expert panel at Biocides Europe in Vienna

Regulators, authorities and biocides businesses are continuing to get to grips with the intricacies of the EU Biocidal Product Regulation – putting the provisions into practice and, where necessary, developing further explanation and understanding of the application of this hugely complex piece of legislation.

As implementation progresses, an increasing number of companies, across more industrial sectors, are feeling the effects and increasingly need to know their obligations in order to remain within the law. Companies also need to understand the likely impacts of the regulation on the supply of ingredients that are often critical to the performance of their products.

The 2018 conference focused on key aspects of Regulation (EU) No. 528/2012 concerning the approval of active substances and authorisation of biocidal products. Presentations included the latest developments from the European Commission and ECHA. As well as drilling down to the recent detail of this complex regulation, speakers addressed topics such as:

  • Biocidal Product Families updates
  • In situ product authorisation
  • Dietary and nanomaterial risk assessment
  • The impact of Brexit
  • Data sharing issues - BPR related cases at the Board of Appeal
  • The implementation of ED criteria under the BPR
  • Innovation: new biocides and alternatives
  • Strategy for efficacy testing for disinfectants in biocidal product families
  • Efficacy testing for PT 11/12 and PT 18/19
  • Compliance strategies with the BPR
  • Developments from the FORUM subgroup including update on first project REF-6
  • Biocides regulation in South Korea, China and Canada

Biocides Europe 2018 was chaired by David Dillon, Senior Managing Scientist, Exponent International Ltd.